P/E at 64.96 vs Industry's 62.98: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Premium P/E in a Competitive Sector

Apollo Hospitals Enterprise Ltd. trades at a P/E of 64.96, slightly above the hospital industry average of 62.98. This premium, while not extreme, suggests investors are willing to pay more for the company’s earnings relative to its peers. The valuation premium may reflect expectations of superior earnings growth or operational efficiency, but it also raises questions about sustainability in a sector where margins can be pressured by regulatory and competitive factors. The P/E differential is a key metric to monitor — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in this valuation premium alongside other performance indicators.

Performance Across Timeframes: Strong Long-Term Gains Amid Mixed Short-Term Signals

The stock’s performance over the past year has been robust, delivering a 20.04% gain compared to the Sensex’s 6.89% loss. This outperformance extends over longer horizons, with three-year returns at 71.15%, five-year returns at 137.08%, and an impressive ten-year return of 544.87%, all substantially ahead of the Sensex’s respective 18.54%, 47.87%, and 185.55%. Such figures underscore Apollo Hospitals Enterprise Ltd. as a long-term outperformer in the hospital sector.

However, the short-term momentum is less consistent. The stock declined by 0.72% over the past week and is down 0.11% on the day, while the Sensex gained 0.94% today. Over the last month, the stock rose 4.08%, slightly underperforming the Sensex’s 4.70%. Notably, the three-month return stands at 17.55%, a strong figure compared to the Sensex’s flat performance of -0.11%. This divergence between short and medium-term returns — is this a recovery or a dead-cat bounce? — highlights the importance of timeframe when analysing momentum.

Moving Average Configuration: Bullish Across All Key Averages

The technical picture for Apollo Hospitals Enterprise Ltd. is notably positive. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, signalling a broad-based uptrend across short, medium, and long-term horizons. This configuration suggests sustained buying interest and a strong technical foundation, which supports the recent gains and may provide a cushion against volatility. The stock’s proximity to its 52-week high — just 0.54% away — further emphasises its resilience in recent months.

Sector Context: Hospital Industry Performance and Stock Positioning

The hospital sector has experienced mixed results recently, with some companies facing margin pressures and regulatory challenges. Despite this, Apollo Hospitals Enterprise Ltd. has maintained a strong market capitalisation of ₹1,27,010.74 crores, reflecting its status as a large-cap leader in the hospital industry. The sector’s average P/E of 62.98 indicates a competitive valuation environment, where premium multiples are justified by growth and operational metrics. The stock’s ability to sustain a premium P/E while outperforming the Sensex over multiple timeframes suggests it remains a key player within its sector.

Rating Context: Previously Rated Hold, Now Reassessed

MarketsMOJO’s previous rating for Apollo Hospitals Enterprise Ltd. was Hold, with a Mojo Score of 75.0. The rating was updated on 11 May 2026, reflecting a reassessment of the company’s fundamentals, valuation, and technicals. This change coincides with the stock’s strong long-term performance and its current premium valuation. The reassessment takes into account the stock’s consistent gains, positive moving average configuration, and sector dynamics — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Data-Driven View of Apollo Hospitals’ Current Standing

The data for Apollo Hospitals Enterprise Ltd. paints a picture of a large-cap hospital stock trading at a slight premium to its industry peers, supported by strong long-term returns and a bullish technical setup. While short-term performance shows some volatility, the stock’s position above all key moving averages and its proximity to a 52-week high indicate underlying strength. The reassessment of its rating from Hold reflects these factors, balancing valuation with performance and sector context. Investors analysing this stock should consider the interplay of premium valuation and sustained outperformance — what is the current rating for Apollo Hospitals Enterprise Ltd.?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →